Immune checkpoint inhibitor‐associated interstitial lung diseases correlate with better prognosis in patients with advanced non‐small‐cell lung cancer

BACKGROUND: Interstitial lung disease (ILD) induced by immune checkpoint inhibitors (ICIs) is a potentially life‐threatening adverse event. The purpose of this study was to evaluate whether the development of immune‐related adverse events (irAEs), especially ILD, was associated with treatment effica...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Thorac Cancer
Autori principali: Sugano, Teppei, Seike, Masahiro, Saito, Yoshinobu, Kashiwada, Takeru, Terasaki, Yasuhiro, Takano, Natsuki, Hisakane, Kakeru, Takahashi, Satoshi, Tanaka, Toru, Takeuchi, Susumu, Miyanaga, Akihiko, Minegishi, Yuji, Noro, Rintaro, Kubota, Kaoru, Gemma, Akihiko
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons Australia, Ltd 2020
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7113045/
https://ncbi.nlm.nih.gov/pubmed/32096610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13364
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi